Global Markets Direct’s, ‘Seborrhea Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Seborrhea, complete with latest updates, and special features on late-stage and discontinued projects. It also […]
December 2013 Life Science Industry Research Reports
Community-Acquired Infections – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Community-Acquired Infections Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Community-Acquired Infections, complete with latest updates, and special features on late-stage and discontinued projects. […]
Androgenic Alopecia – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Androgenic Alopecia Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Androgenic Alopecia, complete with latest updates, and special features on late-stage and discontinued projects. […]
Acute Promyelocytic Leukemia – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Acute Promyelocytic Leukemia Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Acute Promyelocytic Leukemia, complete with latest updates, and special features on late-stage and […]
Vasomotor Symptoms of Menopause – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Vasomotor Symptoms of Menopause Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Vasomotor Symptoms of Menopause, complete with latest updates, and special features on […]
Skin And Soft Tissue Infections – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Skin And Soft Tissue Infections Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Skin And Soft Tissue Infections, complete with latest updates, and special […]
Retinoblastoma – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Retinoblastoma Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Retinoblastoma, complete with latest updates, and special features on late-stage and discontinued projects. It also […]
Trypanosomiasis – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Trypanosomiasis Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Trypanosomiasis, complete with latest updates, and special features on late-stage and discontinued projects. It also […]
General Anxiety Disorder – Pipeline Review, H2 2013
Global Markets Direct’s, ‘General Anxiety Disorder Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for General Anxiety Disorder, complete with latest updates, and special features on late-stage and […]
Food Allergy – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Food Allergy Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Food Allergy, complete with latest updates, and special features on late-stage and discontinued projects. […]
Stay In Touch